SOURCE: EXTEDO

June 23, 2009 08:00 ET

Glenmark Pharmaceuticals Standardizes on EXTEDO Electronic Submissions Management Solution Across Global Operations

WEST CHESTER, PA--(Marketwire - June 23, 2009) - EXTEDO, a key eSubmission solutions provider for life sciences firms, today announced that Glenmark Pharmaceuticals Ltd., a research-driven, global, pharmaceutical company, has selected the eCTDmanager Suite™ for use across the organization.

The EXTEDO eCTDmanager Suite provides Glenmark Pharmaceuticals with an easy-to-use electronic management solution for building, viewing, validating, and publishing compliant submissions that meet global regulatory specifications.

"Glenmark Pharmaceuticals is a global entity that does business in over 90 countries. We needed a flexible submission solution that could handle the complex filing requirements mandated by regulators in different geographies," stated William McIntyre, Vice President of Regulatory Affairs at Glenmark. "The EXTEDO solution exceeded our selection criteria and provides us with a scalable solution that we can roll out across the organization."

"We are looking forward to working with Glenmark and helping them deploy eCTDmanager in their facilities located in India, Europe, South America, and North America," said Andreas Suchanek, Managing Director for EXTEDO.

About Glenmark Pharmaceuticals Ltd. (GPL)

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. Glenmark is the leader in India in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has a significant presence in branded generics markets across emerging economies including India. It also has a fast growing and robust US generics business. Its stock is listed on India's two large stock exchanges, the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Glenmark employs over 5000 people across its global operations across 95 countries. Glenmark was recently awarded by SCRIP, the largest selling and most respected pharmaceutical magazine in the world as the "Best Pharma company in the World - SME" and "Best company across Emerging markets" for 2008. Forbes, another leading international publication recognized Glenmark as the "Best Under a Billion Dollar companies in Asia" for 2008.

About EXTEDO

For nearly 15 years EXTEDO has been a key services and solutions provider in the field of regulatory data and document management (CTD, eCTD and other formats) for Life Sciences industries and authorities (Pharmaceutical, Crop Science, Chemicals). Based on well-founded expertise and many years of experience, EXTEDO provides highly standardized as well as customized solutions in the area of electronic Regulatory Affairs.

EXTEDO, being globally represented, serves more than 600 Life Sciences organizations in more than 50 countries.

For more information visit www.extedo.com.

All trade names, trademarks, and service marks are the rightful property of their respective owners.

Contact Information

  • Media Contact:
    Michael Kane
    EXTEDO
    Tel: (978) 257-2179
    Email: Email Contact